European Investment Bank (EIB) considering extending maturity of its financial facility contract with Scinai Immunotherapeutics in light of Scinai’s recent strategic pivot
31 oct. 2023 09h00 HE
|
Scinai Immunotherapeutics Ltd.
Recently rebranded Scinai Immunotherapeutics shifted drug development focus from COVID-19 antibody to a novel antibody for the treatment of psoriasis and launched a CDMO business unitAdjusted terms...
Biostimulants- Eco-friendly organic materials providing cost effective solution, expanding at a CAGR of 10.7% during 2018 – 2024
15 oct. 2018 05h55 HE
|
Energias Market Research
NEW YORK, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Global biostimulants market size is expected to reach USD 3,768.7 Million in 2024, at a CAGR of 10.7% from 2018 to 2024. Factors propelling the growth of...